Corporates
LogoName Σ
Erganeo Erganeo

Dare the future Erganeo is a team of passionate people, who defend the utopia of bringing scientific innovation to the economic world, so that the industry of the future is above all at the service of people. Licensing, Innovation, DeepTech, Start-up, Technology Transfer, Futur, Industry, Research, Environmental Sustainability, Societal impact, Medical, and Health

Tags: SATT Network Sectors: National and local authorities Research

115 28 53
Estimeo Estimeo

[Automatic translation follows] Startup and VSE/SME valuation - UGAP rating - Support for fundraising and Sale/Acquisition Estimeo is an information, rating and valuation platform for startups and VSEs/SMEs. Estimeo, through a hybrid method combining algorithm and human intelligence, analyzes risks, rates and values ​​startups. The rating and valuation reports taking into account the intangible are then distributed via a platform where all the players in the innovation ecosystem connect. The notes allow innovators to know themselves better, to analyze the progress of their projects and consequently to enter into relationships with investors, incubators and business partners. Estimeo's mission, as a …

Sectors: Consulting

556 38 542
Kurma Partners Kurma Partners

Our Vision : We have High Standards - We Build Companies - We have Impact Kurma Partners is a key European venture capital group specialized in healthcare, with €470 million under management, with two dedicated franchises : Kurma Biofund focused on therapeutic (current active fund KBIII) and Kurma Diagnostics focused on diagnostic and digital health (current active fund Kurma Dx2). Biotechnology, Lifesciences, Drug Development, Technology transfer, Rare diseases, Digital Healh, Diagnostics, and Medtech

Sectors: Startup accelerator & VC

81 58 20
Novartis Novartis

Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Find out more at https://www.novartis.com See our community guidelines: https://go.novartis.social/3Nboxki Cardiovascular, Immunology, Neuroscience, Solid Tumors, Hematology, Chemistry, xRNA, Radioligand, and Gene and cell therapy

Sectors: Pharmaceutical

593 498 52